Toxicity testing of human assisted reproduction devices using the mouse embryo assay.
until further notice
SourceReproductive Biomedicine Online, 18, 4, (2009), pp. 529-535
Article / Letter to editor
Display more detailsDisplay less details
Epidemiology, Biostatistics & HTA
Centre for Quality of Care Research
Reproductive Biomedicine Online
SubjectNCEBP 12: Human Reproduction; NCEBP 1: Molecular epidemiology; NCEBP 2: Evaluation of complex medical interventions; NCEBP 12: Human Reproduction
Systems to assess the toxicity of materials used in human assisted reproduction currently lack efficiency and/or sufficient discriminatory power. The development of 1-cell CBA/B6 F1 hybrid mouse embryos to blastocysts, expressed as blastocyst rate (BR), is used to measure toxicity. The embryos were divided into control and test groups, and were exposed to either control medium or to a potentially toxic test medium. Inferences on toxicity were based on differences in BR between the two groups. The mouse embryo assay followed a stratified (mouse), randomized (embryo), and balanced (equal number of embryos per group and per mouse) design. The number of embryos needed was calculated using power analysis. The basal BR of the hybrid strain was determined in a historical population. Sixty-nine mouse embryos per group were required to detect toxic materials with sufficient sensitivity and to account for the considerable inter-mouse variation in blastocyst development. Fifty-two samples, divided over batches of seven different products were tested before use in the study IVF centre and five of these were found to be toxic. This test system, presented as the Nijmegen mouse embryo assay (NMEA), can be used to detect embryo-toxic materials in daily IVF practice, and this report may provide a starting point for standardization.
Upload full text